BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/18/2020 5:58:43 AM | Browse: 509 | Download: 679
Publication Name World Journal of Hepatology
Manuscript ID 58594
Country Japan
Received
2020-07-28 22:05
Peer-Review Started
2020-07-28 22:06
To Make the First Decision
Return for Revision
2020-09-17 17:14
Revised
2020-09-29 16:01
Second Decision
2020-10-21 12:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-10-21 16:48
Articles in Press
2020-10-21 16:48
Publication Fee Transferred
Edit the Manuscript by Language Editor
2020-10-31 23:41
Typeset the Manuscript
2020-12-10 02:45
Publish the Manuscript Online
2020-12-18 05:58
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Case Report
Article Title Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report
Manuscript Source Invited Manuscript
All Author List Hideki Yokoo, Hiroyuki Takahashi, Masahiro Hagiwara, Hiroyoshi Iwata, Koji Imai, Yoshinori Saito, Naoto Matsuno and Hiroyuki Furukawa
ORCID
Author(s) ORCID Number
Hideki Yokoo http://orcid.org/0000-0002-6203-8528
Hiroyuki Takahashi http://orcid.org/0000-0003-2876-5964
Masahiro Hagiwara http://orcid.org/0000-0002-2589-3955
Hiroyoshi Iwata http://orcid.org/0000-0002-3970-0827
Koji Imai http://orcid.org/0000-0001-9318-1450
Yoshinori Saito http://orcid.org/0000-0002-9861-0442
Naoto Matsuno http://orcid.org/0000-0001-5186-7331
Hiroyuki Furukawa http://orcid.org/0000-0003-3559-4155
Funding Agency and Grant Number
Corresponding Author Hideki Yokoo, MD, PhD, Associate Professor, Division of Hepato-Biliary-Pancreatic Surgery and Transplant Surgery, Department of Surgery, Asahikawa Medical University, 2-1 Midorigaoka-Higashi, Asahikawa 078-8510, Hokkaido, Japan. hidekiyokoo@asahikawa-med.ac.jp
Key Words Conversion to surgery; Lenvatinib; Recurrent hepatocellular carcinoma; Case report; Neoadjuvant therapy; Molecular targeted therapy
Core Tip Lenvatinib was shown to be noninferior to sorafenib for unresectable hepatocellular carcinoma (HCC), and tumor shrinkage was observed in ~40% of cases. We report a case of intrahepatic HCC recurrence with rapid growth and sternal bone metastases after initial resection of HCC, in which conversion to second surgery was successfully achieved after lenvatinib administration induced tumor shrinkage. Regarding histopathological findings, 80% of the tumor was necrotic and the resected margin of the liver surface showed no cancer component. Tumor marker PIVKA-II decreased to the normal range after surgery. Because the patient had bone metastases, multidisciplinary therapy, postoperative radiation therapy, and lenvatinib administration were performed, and the patient remains alive at 1 year postoperatively. In this case, lenvatinib induced a partial response for rapid growth of recurrent HCC with bone metastases, and conversion to surgery was successfully achieved for the purpose of controlling the intrahepatic lesion for the first time.
Publish Date 2020-12-18 05:58
Citation Yokoo H, Takahashi H, Hagiwara M, Iwata H, Imai K, Saito Y, Matsuno N, Furukawa H. Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report. World J Hepatol 2020; 12(12): 1349-1357
URL https://www.wjgnet.com/1948-5182/full/v12/i12/1349.htm
DOI https://dx.doi.org/10.4254/wjh.v12.i12.1349
Full Article (PDF) WJH-12-1349.pdf
Full Article (Word) WJH-12-1349.docx
CARE Checklist–2016 58594-CARE-Checklist–2016-revision.pdf
Manuscript File 58594-Review-Filipodia.docx
Answering Reviewers 58594-Answering reviewers.pdf
Audio Core Tip 58594-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 58594-Conflict-of-interest statement.pdf
Copyright License Agreement 58594-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 58594-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate 58594-Language certificate.pdf
Peer-review Report 58594-Peer-review(s).pdf
Scientific Misconduct Check 58594-Scientific misconduct check.pdf
Scientific Editor Work List 58594-Scientific editor work list.pdf